INSM

Martina M.D. Flammer

Known title: Chief Medical OfficerCIK: 0001796960

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Wolfe Research Downgrades Insmed to Peer Perform Ahead of CHEST 2026. Wolfe Research lowered its rating on Insmed to Peer Perform, joining a wave of recent analyst downgrades. This move comes as the company prepares to present new data for its respiratory portfolio, including the Phase 3 PALM program, at the CHEST 2026 conference. While the stock is currently trading near its 52-week low, other analysts like HC Wainwright remain bullish with a $220 price target.

this person other insiders at INSM

Transaction History

INSM▲ Buy$346K
INSM▲ Buy$230K
INSM▼ Sell$1.1M
INSM▼ Sell$2.4M
INSM▲ Buy$231K
INSM▲ Buy$86K
INSM▼ Sell$529K
INSM▼ Sell$824K
INSM▼ Sell$193K
INSM▼ Sell$262K
INSM▼ Sell$1.2M
INSM▼ Sell$504K
INSM▼ Sell$393K
INSM▲ Buy$221K
INSM▼ Sell$1.2M
INSM▼ Sell$84K
INSM▼ Sell$132K
INSM▼ Sell$124K
INSM▼ Sell$16K
INSM▲ Buy$525K
INSM▼ Sell$86K
INSM▼ Sell$142K
INSM▼ Sell$518K
INSM▼ Sell$473K
INSM▼ Sell$351K
INSM▼ Sell$289K
INSM▼ Sell$566K
INSM▼ Sell$252K
INSM▼ Sell$280K
INSM▲ Buy$227K
INSM▼ Sell$830K
INSM▼ Sell$493K
INSM▼ Sell$167K
INSM▲ Buy$86K
INSM▲ Buy$231K
INSM▼ Sell$474K
INSM▼ Sell$547K
INSM▼ Sell$485K
INSM▼ Sell$49K
INSM▼ Sell$316K
INSM▼ Sell$114K
INSM▼ Sell$123K
INSM▲ Buy—
INSM▲ Buy—
INSM▼ Sell$299K
INSM▲ Buy$230K
INSM▼ Sell$1.2M
INSM▼ Sell$324K
INSM▼ Sell$2.0M
INSM▼ Sell$556K
INSM▲ Buy$346K
INSM▼ Sell$1.0M
INSM▼ Sell$2.3M
INSM▲ Buy$221K
INSM▲ Buy$466K
INSM▲ Buy$454K
INSM▲ Buy$680K
INSM▲ Buy$663K
INSM▲ Buy$258K
INSM▲ Buy$693K
INSM▲ Buy$694K
INSM▲ Buy$460K
INSM▼ Sell$2.7M
INSM▼ Sell$835K
INSM▼ Sell$5.0M
INSM▼ Sell$4.0M
INSM▼ Sell$9.3M
INSM▼ Sell$5.1M
INSM▲ Buy$172K
INSM▼ Sell$954K
INSM▲ Buy$332K
INSM▼ Sell$1.8M
INSM▼ Sell$2.3M
INSM▲ Buy$681K
INSM▼ Sell$121K
INSM▼ Sell$121K
INSM▲ Buy$0
INSM▼ Sell$650K
INSM▼ Sell$114K
INSM▼ Sell$570K
INSM▼ Sell$399K
INSM▼ Sell$749K
INSM▼ Sell$1.8M
INSM▼ Sell$5K
INSM▼ Sell$2.7M
INSM▲ Buy$0
INSM▼ Sell$95K
INSM▼ Sell$87K
INSM▼ Sell$305K
INSM▼ Sell$113K
INSM▲ Buy—
INSM▼ Sell$220K
INSM▼ Sell$1.0M
INSM▲ Buy$457K
INSM▼ Sell$2.0M
INSM▲ Buy$918K
INSM▼ Sell$48K
INSM▲ Buy$22K
INSM▲ Buy$336K
INSM▲ Buy$332K
INSM▲ Buy$906K
INSM▼ Sell$658K
INSM▲ Buy$447K
INSM▲ Buy$693K
INSM▼ Sell$4.5M
INSM▼ Sell$5.4M
INSM▲ Buy$681K
INSM▲ Buy$503K
INSM▼ Sell$1.3M
INSM▲ Buy$503K
INSM▼ Sell$1.2M
INSM▲ Buy$2.5M
INSM▼ Sell$5.2M
INSM▼ Sell$116K
INSM▼ Sell$271K
INSM▲ Buy—
INSM▼ Sell$134K
INSM▼ Sell$36K
INSM▼ Sell$137K
INSM▼ Sell$40K
INSM▲ Buy—
INSM▲ Buy$670K
INSM▼ Sell$849K
INSM▼ Sell$171K
INSM▼ Sell$32K
INSM▼ Sell$50K
INSM▲ Buy—
INSM▲ Buy—
INSM▼ Sell$62K
INSM▲ Buy—
INSM▼ Sell$27K
INSM▲ Buy—
INSM▼ Sell$29K
INSM▲ Buy—
INSM▼ Sell$38K
INSM▲ Buy—
INSM▼ Sell$39K

We use analytics to understand how market-wall is used. No personal data is sold.